GE HealthCare to Acquire SOFIE Bioscience for $945 million
GEHC GE HealthCare Technologies Inc
$65.74 +2.26%
View chart & analysis → - 1GE HealthCare Technologies has agreed to acquire SOFIE Bioscience from Trilantic North America in a $945 million cash deal.
- 2GEHC shares rose more than 1% on Monday.
- 3Citi lowered its price target for GE HealthCare from $75 to $71.
So what's the key point?
GE HealthCare has decided to buy SOFIE Bioscience for $945 million. Experts do not expect this company's stock to rise further in the future.
Source The Wall Street Journal +3 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.